| This is the talk page for discussing improvements to the Alipogene tiparvovec article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Alipogene tiparvovec.
|
Cost edit
www.naturalnews.com/038661_Big_Pharma_gene_therapy_drugs.html [unreliable fringe source?] ] says it may cost $1M per patient. Any RS ? - Rod57 (talk) 15:07, 13 January 2013 (UTC)
Clinical trials and duration of benefit edit
What trial results and how long do the effects last ? - Rod57 (talk) 15:18, 13 January 2013 (UTC)
History edit
doi:10.1089/hum.2013.063 describes the discovery in first-person account by Kastelein, Ross & Hayden. JFW | T@lk 07:50, 15 December 2013 (UTC)
Another good source for a future History section would be the review article http://www.ncbi.nlm.nih.gov/pubmed/23808604 . AxelBoldt (talk) 18:55, 11 March 2015 (UTC)